Host or pathogen-related factors in COVID-19 severity?
作者信息
Gortázar Christian, Del-Río Francisco J Rodríguez, Domínguez Lucas, de la Fuente José
机构信息
SaBio, Instituto de Investigación en Recursos Cinegéticos, Consejo Superior de Investigaciones Científicas, Universidad de Castilla-La Mancha, Ciudad Real 13005, Spain.
Local Medical Service Horcajo de los Montes, Ciudad Real, Spain.
出版信息
Lancet. 2020 Oct 31;396(10260):1396-1397. doi: 10.1016/S0140-6736(20)32215-7.
Abstract
摘要
相似文献
1
Host or pathogen-related factors in COVID-19 severity?新冠病毒肺炎严重程度中的宿主或病原体相关因素？
Lancet. 2020 Oct 31;396(10260):1396-1397. doi: 10.1016/S0140-6736(20)32215-7.
2
Host or pathogen-related factors in COVID-19 severity? - Authors' reply.新冠病毒疾病严重程度中的宿主或病原体相关因素？——作者回复
Lancet. 2020 Oct 31;396(10260):1397. doi: 10.1016/S0140-6736(20)32212-1.
3
To achieve "zero covid" we need to include the controlled, careful acquisition of population (herd) immunity.要实现“动态清零”，我们需要纳入可控、审慎地获取群体免疫这一要素。
BMJ. 2020 Sep 9;370:m3487. doi: 10.1136/bmj.m3487.
4
Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?逐步且可控的群体保护方法是遏制新冠疫情的有效策略吗？
Indian Pediatr. 2020 Jun 15;57(6):505-507. doi: 10.1007/s13312-020-1844-4. Epub 2020 May 6.
5
Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.群体免疫——评估受影响国家遏制新冠疫情所需的群体免疫水平。
J Infect. 2020 Jun;80(6):e32-e33. doi: 10.1016/j.jinf.2020.03.027. Epub 2020 Mar 21.
6
COVID-19: Mitigation or suppression?新冠病毒病：缓解还是抑制？
Arab J Gastroenterol. 2020 Mar;21(1):1-2. doi: 10.1016/j.ajg.2020.04.010.
7
Herd immunity and COVID-19.群体免疫与新冠病毒病
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4064-4065. doi: 10.26355/eurrev_202004_20978.
8
Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.长期和群体免疫对 SARS-CoV-2 的影响：基于当前和既往知识的推断。
Pathog Dis. 2020 Apr 1;78(3). doi: 10.1093/femspd/ftaa025.
9
Overcoming fragmentation of health research in Europe: lessons from COVID-19.克服欧洲卫生研究的碎片化：来自新冠疫情的教训。
Lancet. 2020 Jun 27;395(10242):1970-1971. doi: 10.1016/S0140-6736(20)31411-2. Epub 2020 Jun 16.
10
EU health law and policy in and after the COVID-19 crisis.新冠疫情危机期间及之后的欧盟卫生法律与政策。
Eur J Public Health. 2020 Aug 1;30(4):623-624. doi: 10.1093/eurpub/ckaa088.
引用本文的文献
1
Art-science multidisciplinary collaborations to address the scientific challenges posed by COVID-19.艺术-科学多学科合作应对 COVID-19 带来的科学挑战。
Ann Med. 2022 Dec;54(1):2535-2548. doi: 10.1080/07853890.2022.2123557.
2
Four-month intrinsic viral cycle in COVID-19.新冠病毒四个月的固有病毒周期。
Innovation (Camb). 2022 Jan 25;3(1):100196. doi: 10.1016/j.xinn.2021.100196. Epub 2021 Dec 14.
3
Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.采用定量血清蛋白质组学对 COVID-19 症状的免疫相关预后生物标志物进行表征。
Front Immunol. 2021 Sep 8;12:730710. doi: 10.3389/fimmu.2021.730710. eCollection 2021.
4
The sound of host-SARS-CoV-2 molecular interactions.宿主与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）分子相互作用的声音。
Innovation (Camb). 2021 Aug 28;2(3):100126. doi: 10.1016/j.xinn.2021.100126. Epub 2021 Jun 8.
5
Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE.节肢动物外寄生虫有可能通过 ACE 结合 SARS-CoV-2。
Viruses. 2021 Apr 19;13(4):708. doi: 10.3390/v13040708.
6
Immunity to glycan α-Gal and possibilities for the control of COVID-19.对聚糖α-Gal的免疫及控制新冠病毒病的可能性
Immunotherapy. 2021 Feb;13(3):185-188. doi: 10.2217/imt-2020-0247. Epub 2020 Dec 14.
本文引用的文献
1
Have deaths from COVID-19 in Europe plateaued due to herd immunity?欧洲因群体免疫而导致的新冠死亡人数是否已趋于平稳？
Lancet. 2020 Jun 20;395(10241):e110-e111. doi: 10.1016/S0140-6736(20)31357-X. Epub 2020 Jun 11.
2
Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）基因组中碱基突变的全基因组鉴定与特征分析
Osong Public Health Res Perspect. 2020 Jun;11(3):101-111. doi: 10.24171/j.phrp.2020.11.3.05.
Zotero 插件